drugset / Trial / NCT00354042

Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects

NCT00354042 ↗

Phase 1 Completed 24 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This study is designed to look at the safety aspects and effects of repeat inhaled doses of GW597901X in asthmatics to develop this drug for its use in asthma and Chronic Obstructive Pulmonary Disease(COPD).

Timeline

Start
2004-08
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject GW597901X Unknown — Inhaled

Indications